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Background
Severe pulmonary regurgitation, progressive dilatation and
dysfunction of the right ventricle are the most frequent
reason of late morbidity post Fallot repair. Pulmonary
valve replacement is often indicated in these patients.
BioIntegral Injectable pulmonary valve (IPV) is an innova-
tive less invasive technique, often done off cardiopulmon-
ary bypass (CPB). Cardiovascular Magnetic Resonance
(CMR) is fundamental tool to assess patient suitability for
IPV insertion and in the clinical follow up.
Methods
From January 2006 to June 2012, 10 patients undergoing a
pulmonary valve replacement due to end-diastolic volume
overload and pulmonary regurgitation (PR) assessed at
CMR pre-surgery examination underwent IPV insertion.
We performed a full CMR (Achieva, 1.5 Tesla Philips)
examination including right ventricular volume measure-
ments, velocity encoded sequences and 3DSSFP ecg and
respiratory gated with a navigator tecnique to asses pul-
monary artery diameters.
In particular we measured pulmonary diameters in sys-
tole at the following sites: at the level of right ventricular
patch, at the pulmonary valve and at the bifurcation and
the length of the pulmonary trunk.
Suitability for IPV approach included a pulmonary trunk
length more than 20 mm and a trunk diameter between
15 and 31 mm, due to the dimension of the biointegral
valve.
For more than 31 mm diameter a pulmonary arterio-
plasty was needed.
5 of these patients underwent also a CMR 3 months to
6 years follow-up.
Results
IPV was successful and with an excellent hemodynamic
performance in all 10 patients.
Only 3 patients underwent concomitant procedures on
CPB and no-one underwent reduction plasty of a dilated
main pulmonary artery.
Early recovery was uneventful. There were no
reoperations.
At the latest follow-up 3 months to 6 years post IPV
insertion CMR showed an improvement of right ventricle
end diastolic volume. The IPV was continent in the major-
ity of the patients with no flow acceleration measured. We
just reported a case of paraprosthetic mild to moderate
PR.
Conclusions
CMR is a safe and effective method to asses patient suit-
ability for IPV insertion.
In the follow up CMR measure the pulmonary valve
efficiency, the transvalvular gradients and the right ven-
tricle function.
IPV is also better detected by CMR than traditional
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Figure 1 3D Whole-heart imaging of the MPA pre (A) and post (C) IPV implantation shows well seated device according to the draft (B) with low
magnetic susceptibility of the device and adequate intra-stent visualization (no need for furter investigation such as CT or catheter).
Figure 2 Balanced SSFP cine imaging of the RVOT post IPV implantation in systole (A) and diastole (B) allows good functional assessment of the valve
leaflets. This is comparable to native valves such as aorta and tricuspid, as showed in the RV in and out view (C)
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